Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Comparative Effectiveness Research Recommendations
Statement by APTA President R. Scott Ward, PT, PhD
generic viagra online
Electronic Pill Shows Its Smarts By Measuring PH Levels In Digestive Tract
An electronic diagnostic tool called the SmartPill is swallowed by patients in order to take measurements as it travels through the gastrointestinal tract. A new study by physician-scientists at NewYork-Presbyterian/Weill Cornell Medical Center used the device in patients with mild to moderate ulcerative colitis (UC), determining that they have significantly more acidic pH in their colons, compared with the average person -- a finding that may impact treatment strategy.
News of the day
Novavax Announces Selection Of A Respiratory Syncytial Virus Vaccine Candidate For Advanced Preclinical Studies
Novavax, Inc. (Nasdaq: NVAX) announced final selection of a Respiratory Syncytial Virus (RSV) vaccine candidate that will be advanced into additional preclinical studies to support an Investigational New Drug (IND) application. As previously announced, Novavax has been evaluating a number of RSV vaccine candidates, all of which have successfully induced antibody responses in mice. Novavax scientists have now engineered a new vaccine candidate which has been shown to protect mice against RSV disease and can be produced at sufficient yields to allow commercial manufacture. This new candidate is directed against a protein on the surface of the virus, the "F" or "fusion" protein, which is the protein that the virus uses to infect and fuse with cells in the respiratory tract and cause disease.
Nutrition

MS Society Commends Federal Government's Research Investment In Neurological Diseases

The Multiple Sclerosis Society of Canada praised the government"s announcement of $15 million to study the impact of a wide variety of neurological conditions, including multiple sclerosis. "The MS Society applauds the federal government"s $15 million commitment to pursue a greater understanding of neurological diseases and injuries," said Yves Savoie, president and CEO of the MS Society of Canada. "In the field of MS, we anticipate the results of this work will help guide our efforts to fund the best research and deliver programs that positively impact quality of life." The four-year national population study will provide key information to improve current knowledge about the prevalence, risk factors, use of health services, economic cost, and impact of neurological conditions currently and projected over the next 20 years. A comprehensive report will be published in the final year of the study. "This commitment would not be possible without the leadership and guidance of Neurological Health Charities Canada (NHCC), in which the MS Society plays an active role," said Savoie. NHCC is a collective of organizations that represent people with chronic, progressive brain diseases, disorders, and injuries in Canada that have been actively advocating for a national brain strategy. "Many thanks to the leaders of the NHCC, including the MS Society"s Deanna Groetzinger, vice president, government relations and policy, for advancing the need for this study and for securing this very timely and important commitment from the government," said Savoie. About multiple sclerosis and the Multiple Sclerosis Society of Canada Multiple sclerosis is a chronic, often disabling disease of the brain and spinal cord. It is the most common neurological disease of young adults in Canada. Most people with MS are diagnosed between the ages of 15 and 40, and the unpredictable effects of MS last for the rest of their lives. The MS Society provides services to people with MS and their families and funds research to find the cause and cure for this disease. About Neurological Health Charities Canada Neurological Health Charities Canada (NHCC) is a collective of organizations that represent people with chronic, often progressive, neurological and/or neuromuscular diseases, disorders, conditions and injuries in Canada. The NHCC"s role is to provide leadership, evaluating and advancing new opportunities for collaboration specific to advocacy, education and research projects, related to brain health. NHCC members include: ALS Society of Canada, Alzheimer Society of Canada, Canadian Neurological Sciences Federation, Canadian Alliance of Brain Tumor Organizations, Dystonia Medical Research Foundation Canada, Epilepsy Ontario, Huntington Society of Canada, March of Dimes, Mood Disorder Society of Canada, MS Society of Canada, Muscular Dystrophy Canada, NeuroScience Canada, Ontario Federation for Cerebral Palsy, Ontario Neurotrauma Foundation, Parkinson Society Canada, Spina Bifida & Hydrocephalus Association of Ontario, Tourette Syndrome Foundation of Canada. Neurological Health Charities Canada


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009